The Discounted Cash Flow (DCF) valuation of Astrazeneca Pharma India Ltd (ASTRAZEN.NS) is 1,125.14 INR. With the latest stock price at 7,980.00 INR, the upside of Astrazeneca Pharma India Ltd based on DCF is -85.9%.
Based on the latest price of 7,980.00 INR and our DCF valuation, Astrazeneca Pharma India Ltd (ASTRAZEN.NS) is a sell. selling ASTRAZEN.NS stocks now will result in a potential gain of 85.9%.
| Range | Selected | |
| WACC / Discount Rate | 14.2% - 16.4% | 15.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 998.37 - 1,309.28 | 1,125.14 |
| Upside | -87.5% - -83.6% | -85.9% |